Skip to main content
Premium Trial:

Request an Annual Quote

Greg Hannon

Cancer Research UK and the University of Cambridge recently announced Greg Hannon as the new director of the Cancer Research UK Cambridge Institute. Hannon joined the Cancer Research UK Cambridge Institute in 2014 as a senior group leader. Prior to that he spent more than 20 years at Cold Spring Harbor Laboratory where he was a Howard Hughes Medical Institute Investigator and chaired the cancer genetics program as part of the Lab's National Cancer Institute-designated cancer center.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.